PRF Technologies EBIT per osake

Mitä PRF Technologies tekee? PRF Technologies Ltd, listed under the ticker PRFX with ISIN IL0011651580, is a pharmaceutical company based in Tel Aviv-Yafo, Israel. The company operates within the Health Care sector and has a workforce of six employees. PRF Technologies Ltd. went public on September 1, 2020. Its website is https://painreform.com/. The company focuses on reformulating established therapeutics, particularly in the area of pain management. PRF Technologies Ltd. develops reformulated pain therapeutics designed to prolong efficacy, enhance therapeutic outcomes, minimize adverse effects, and improve patient convenience. The company's technology aims to facilitate a faster return of motor function for patients. The company's activities are centered on leveraging existing pharmaceuticals to create more effective and user-friendly treatments without introducing new active ingredients. PRF Technologies Ltd. is engaged in the development of innovative approaches to pain management, emphasizing the optimization of current therapeutic options. PRF Technologies on yksi Eurpooliin suosituimmista yhtiöistä.